Congressional appropriations package expands reporting obligations for PBMs to increase transparency. It also delinks PBM compensation in Medicare from list prices.

A ceiling “maximum fair price” established by the Inflation Reduction Act will end up being an important driver of substantially lower prices for this round of 15 drugs.

The Trump administration says that while it is pushing for lower prices in the U.S. drugmakers will be able to make up the difference by charging higher prices abroad.

Cold cosmic dust grains can link amino acids into protein‑like chains in deep space, suggesting life’s chemistry may begin long before planets form, seeding young worlds.

A protective APOE gene variant is enriched in Super Agers—people over 80 who think like 50‑year‑olds—cutting Alzheimer’s risk and helping preserve sharp memory into old age.

Just five extra minutes of daily activity plus small upgrades to sleep and diet can cut premature death risk and add healthy years, without extreme fitness goals.

Experimental gene therapies like AMT‑130 lower toxic huntingtin protein and significantly slow Huntington’s disease, offering families new hope for longer, better quality lives.

Smart glasses and haptic wearables turn visual scenes into sound and touch, helping blind and low‑vision users read, navigate and interpret social cues with greater independence.

Universal gene‑edited CAR‑T therapies turn donor T cells into off‑the‑shelf cancer treatments, cutting delays and costs while delivering rapid remissions for hard‑to‑treat patients.

Electronic retinal implants such as the PRIMA system bypass damaged cells to restore partial central vision, bringing high‑tech artificial sight closer to everyday clinical reality.